Business
BELLUS Health Appoints Dr. Clarissa Desjardins to its Board of Directors
BELLUS Health Appoints Dr. Clarissa Desjardins to its Board of Directors Canada Ne...
About this update from Bluenergies Ltd.
[{"type":"text","content":"\n\n\n\nBELLUS Health Appoints Dr. Clarissa Desjardins to its Board of Directors\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nLAVAL, QC, Sept. 27, 2017\n\n\n\nLAVAL, QC, Sept. 27, 2017 /CNW/ - BELLUS Health Inc. (TSX: BLU) (BELLUS Health or the Company), a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need, today announced that biotech entrepreneur Dr. Clarissa Desjardins is joining its Board of Directors. \n\n\"We are pleased to welcome Dr. Desjardins to our Board of Directors as she brings a wealth of experience in building successful biotech companies,\" said Dr. Francesco Bellini, Chairman of the Board of BELLUS Health. \"As an award-winning biotech entrepreneur, Dr. Desjardins' experience will be a valuable contribution to the BELLUS Health Board of Directors.\" \n\nDr. Desjardins is the Chief Executive Officer and Founder of Clementia Pharmaceuticals Inc., a clinical stage biopharmaceutical company. In addition to founding Clementia in 2011, she established and helped build two other successful biotech companies: Advanced Bioconcept and Caprion Pharmaceuticals. She earned a Ph.D. in Neurology and Neurosurgery from McGill's Faculty of Medicine, and was a Medical Research Council postdoctoral fellow at the Douglas Hospital Research Centre.\n\nConcurrent with the appointment of Dr. Desjardins, BELLUS Health also announced that Dr. Martin Tolar will be stepping down from the Company's Board of Directors. \"On behalf of the Board of Directors, BELLUS Health would like to thank Dr. Tolar for his valuable contributions and commitment to the Company,\" said Dr. Francesco Bellini.\n\nAbout BELLUS Health (www.bellushealth.com)\n\nBELLUS Health is a biopharmaceutical development company advancing novel therapeutics for conditions with high unmet medical need. Its pipeline of projects includes BLU-5937 for chronic cough and several other partnered clinical-stage drug development programs. BLU-5937, a selective P2X3 antagonist, has the potential to be a best-in-class therapeutic for chronic cough ...